Log in to search using one of your social media accounts:

 

Corrigendum to “LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease” BBAPAP 1865 (6) (2017) 703–714

Publication date: Available online 9 February 2018 Source:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Author(s): A. Schrötter, A. Oberhaus, K. Kolbe, S. Seger, T. Mastalski, F. El Magraoui, E. Hoffmann-Posorske, M. Bohnert, J. Deckert, C. Braun, M. Graw, C. Schmitz, T. Arzberger, C. Loosse, H. Heinsen, H.E. Meyer, T. Müller
Source: Biochimica et Biophysica Acta (BBA) Proteins and Proteomics - Category: Biochemistry Source Type: research

Related Links:

DEMENTIA care can be given by a community, if everyone works together. Dementia signs and symptoms include being confused in familiar places, memory loss and problems keeping track of items. Local communities in rural areas may be able to care for sufferers by following this simple plan, recommended by the Alzheimer ’s Society.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
DEMENTIA care can be given by a community, if everyone works together. Dementia signs and symptoms include being confused in familiar places, memory loss and problems keeping track of items. Local communities in rural areas may be able to care for sufferers by following this simple plan, recommended by the Alzheimer ’s Society.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
DEMENTIA care can be given by a community, if everyone works together. Dementia signs and symptoms include being confused in familiar places, memory loss and problems keeping track of items. Local communities in rural areas may be able to care for sufferers by following this simple plan, recommended by the Alzheimer ’s Society.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Lakshmi S, Prakash P, Essa MM, Qoronfleh WM, Akbar M, Song BJ, Kumar S, Elumalai P Abstract Alzheimer's disease (AD ) is mounting as social and economic encumbrance which are accompanied by deficits in cognition and memory. Over the past decades, Alzheimer's disease (AD) holds the frontline as one of the biggest healthcare issues in the world. AD is an age related neurodegenerative disorder marked by a decline in memory and an impairment of cognition. Inspite of tedious scientific effort, AD is still devoid of pharmacotherapeutic strategies for treatment as well as prevention. Current treatment strategies ...
Source: Frontiers in Bioscience - Elite - Category: Biomedical Science Tags: Front Biosci (Elite Ed) Source Type: research
At what point in the transition from pre-symptomatic Alzheimer disease to mild cognitive impairment do personality changes arise that might indicate future behavioral problems?Journal of the American Geriatrics Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Effect of weak combined static and extremely low-frequency alternating magnetic fields on spatial memory and brain amyloid-β in two animal models of Alzheimer's disease. Electromagn Biol Med. 2018 May 17;:1-11 Authors: Bobkova NV, Novikov VV, Medvinskaya NI, Aleksandrova IY, Nesterova IV, Fesenko EE Abstract Subchronic effect of a weak combined magnetic field (MF), produced by superimposing a constant component, 42 µT and an alternating MF of 0.08 µT, which was the sum of two frequencies of 4.38 and 4.88 Hz, was studied in olfactory bulbectomized (OBE) and transgenic Tg (APPswe, P...
Source: Electromagnetic Biology and Medicine - Category: Physics Tags: Electromagn Biol Med Source Type: research
Authors: Grossberg GT, Alva G, Hendrix S, Ellison N, Kane MC, Edwards J Abstract Memantine extended release (ER) significantly outperformed placebo on co-primary endpoints of Clinician's Interview-based Impression of Change Plus Caregiver Input (CIBIC-Plus) and baseline to endpoint changes on the Severe Impairment Battery (SIB) in a 24-week, randomized trial (NCT00322153) in patients with moderate to severe Alzheimer's disease taking a cholinesterase inhibitor (ChEI). A post hoc analysis compared patients receiving memantine ER/ChEI to placebo/ChEI for time to onset of response and if the response was maintained (a...
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
AbstractHippocampal atrophy measures from magnetic resonance imaging (MRI) are powerful tools for monitoring Alzheimer ’s disease (AD) progression. In this paper, we introduce a longitudinal image analysis framework based on robust registration and simultaneous hippocampal segmentation and longitudinal marker classification of brain MRI of an arbitrary number of time points. The framework comprises two innovative parts: a longitudinal segmentation and a longitudinal classification step. The results show that both steps of the longitudinal pipeline improved the reliability and the accuracy of the discrimination betwee...
Source: Neuroinformatics - Category: Neuroscience Source Type: research
In conclusion, the connection between DNA damage and aging is emphasized by the secretion of senescence-associated proteins during cellular senescence, a phenotype which is activated by DNA damage and is common for both human and mice. Though much progress has been achieved, full understanding of these mechanisms has still a long way to go. XPO1 as a Novel Target for Therapies to Enhance Autophagy https://www.fightaging.org/archives/2018/05/xpo1-as-a-novel-target-for-therapies-to-enhance-autophagy/ Autophagy is the name given to a collection of cellular housekeeping processes that recycle damaged and un...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
DEMENTIA signs and symptoms include memory loss, confusion in conversations and losing interest in hobbies. There are several different types of the condition including dementia with lewy bodies and vascular dementia. Alzheimer ’s disease is the most common form of the disease. This is how long you could live if you have the condition, according to the Alzheimer’s Society.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Alzheimer's | Biochemistry